Ellis GC

References (1)

Title : Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled study - Nauck_2009_Int.J.Clin.Pract_63_46
Author(s) : Nauck MA , Ellis GC , Fleck PR , Wilson CA , Mekki Q
Ref : Int J Clin Pract , 63 :46 , 2009
Abstract : Nauck_2009_Int.J.Clin.Pract_63_46
ESTHER : Nauck_2009_Int.J.Clin.Pract_63_46
PubMedSearch : Nauck_2009_Int.J.Clin.Pract_63_46
PubMedID: 19125992